Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (231-240 of 297) with videos related to

Pageof 30
Sort By:
The Lancet. Respiratory Medicine|July 2, 2021
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D Nathan, Aaron Waxman, Sudarshan Rajagopal, et al.
JCI Insight|April 21, 2026
Low Density Neutrophil Heterogeneity and Spleen Tyrosine Kinase as a Therapeutic Target in SepsisHeather L Teague, Lauren Knabe, Raquel S Da Cruz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2025
Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantationAnanth V Charya, Moon K Jang, Hyesik Kong, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
American Journal of Respiratory Cell and Molecular Biology|October 19, 2013
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosisAndrew R Cullinane, Caroline Yeager, Heidi Dorward, et al.
Transplantation Direct|July 1, 2025
Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft FailureMichael B Keller, Allison Y Lin, Moon Kyoo Jang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
Annals of the American Thoracic Society|October 22, 2021
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring OxygenChristopher S King, Kevin R Flaherty, Marilyn K Glassberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.
Pageof 30

Showing results (231-240 of 297) with videos related to

Sort By:
Pageof 30
The Lancet. Respiratory Medicine|July 2, 2021
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D Nathan, Aaron Waxman, Sudarshan Rajagopal, et al.
JCI Insight|April 21, 2026
Low Density Neutrophil Heterogeneity and Spleen Tyrosine Kinase as a Therapeutic Target in SepsisHeather L Teague, Lauren Knabe, Raquel S Da Cruz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2025
Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantationAnanth V Charya, Moon K Jang, Hyesik Kong, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b studySteven D Nathan, Jürgen Behr, Harold R Collard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
American Journal of Respiratory Cell and Molecular Biology|October 19, 2013
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosisAndrew R Cullinane, Caroline Yeager, Heidi Dorward, et al.
Transplantation Direct|July 1, 2025
Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft FailureMichael B Keller, Allison Y Lin, Moon Kyoo Jang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
Annals of the American Thoracic Society|October 22, 2021
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring OxygenChristopher S King, Kevin R Flaherty, Marilyn K Glassberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.
Pageof 30